polycystic%20ovarian%20syndrome
POLYCYSTIC OVARIAN SYNDROME
Polycystic ovarian syndrome (PCOS) is the accumulation of underdeveloped follicles in the ovaries due to anovulation. It is is characterized by menstrual abnormalities and clinical or biochemical features of hyperandrogenism.
It results mainly from abnormal steroidogenesis that may be caused by insulin resistance leading to hyperinsulinemia.
There is increased sensitivity to androgens and the majority of women have elevated androgen levels.

Polycystic%20ovarian%20syndrome Signs and Symptoms

Introduction

  • Polycystic ovarian syndrome (PCOS) is one of the most common endocrinopathies in women of reproductive age and is characterized by menstrual abnormalities and clinical or biochemical features of hyperandrogenism

Biochemical Profile of PCOS

  • Results mainly from abnormal steroidogenesis that may be caused by insulin resistance leading to hyperinsulinemia
  • There is increased sensitivity to androgens and the majority of women have elevated androgen levels
    • Elevated serum concentrations of luteinizing hormone (LH)
    • Low to normal follicle-stimulating hormone (FSH)
    • Elevated testosterone and androstenedione
    • Low to normal estradiol while estrone level is increased
    • Elevated prolactin
    • Decreased sex hormone binding-globulin (SHBG)
    • Elevated insulin

Etiology

Hyperinsulinemia

  • Hyperinsulinemia is implicated as the major trigger for disordered ovarian function and androgen excess
  • May manifest clinically as part of a metabolic syndrome that includes dyslipidemia, diabetes mellitus (DM) and coronary artery disease (CAD)
  • Prevalence of DM is 7x higher in obese women with PCOS (fivefold higher in Asia), while the incidence of CAD is twofold to fivefold higher in the later years of PCOS patients
  • Increased insulin resistance, diabetes, and metabolic risks are seen in Southeast Asians 

Decreased Sex Hormone-Binding Globulin (SHBG)

  • Causes an increase in levels of free active androgens which accounts for the more marked hirsutism, acne and other manifestations of hyperandrogenism

Elevated Estrone

  • Stimulates hyperplasia of ovarian stroma theca cells, and the unopposed estrogen effects on the endometrium may lead to abnormal uterine bleeding and increased risk of endometrial cancer

Signs and Symptoms

Signs and Symptoms

Hyperandrogenism

  • May manifest clinically as:
    • Hirsutism (excessive growth of hair on androgen-sensitive areas of the skin such as the chin, upper lip, sideburns, sternal, periareolar, umbilical, sacral areas and more markedly on the pubic region and upper thighs)
      • Hirsutism is milder in East Asians
    • Severe cystic and persistent acne
    • Mild virilization
    • Rarely male-pattern alopecia 

Ovarian Dysfunction

  • May clinically manifest as menstrual disturbances: Primary amenorrhea or secondary amenorrhea (ie the absence of menses for >3 months after having had menses), oligomenorrhea, dysfunctional uterine bleeding, or infertility

Polycystic Ovaries

  • Either ≥20 follicles measuring 2-9 mm in diameter or increased ovarian volume (>10 cm3)

Other Signs That May be Present

  • Increased central adiposity and acanthosis nigricans are seen in Southeast Asians

Obesity

  • Central visceral obesity is present in 35-80% of patients
    • Obesity is usually not as severe in women of Mediterranean descent and is lower in East Asians

Hyperpigmentation

  • Found in skin fold creases
  • Acanthosis nigricans may also be observed in some patients
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 May 2020
This second issue revisits the impact EMPA-REG OUTCOME had on clinical practice and helps readers discover how it gives life back to patients through its cardiovascular indication. Learn how it was approved and the possible mechanisms for its cardiovascular benefits.
Pearl Toh, 15 Oct 2020
Cycling was associated with reduced risk for both all-cause and cardiovascular (CV) mortality in people with diabetes, according to a study presented at EASD 2020 Meeting — suggesting that cycling could be encouraged as an activity to prevent deaths in this population who are known to have a higher mortality risk than the general public.
Stephen Padilla, 22 Jul 2019
Zinc supplementation significantly lowers key glycaemic indicators, particularly fasting glucose (FG) in individuals with diabetes and in those who received an inorganic supplement, results of a systematic review and meta-analysis have shown.
Elaine Soliven, 15 Oct 2020

Higher levels of exercise appear to be associated with a lower risk of all-cause mortality in adults with type 2 diabetes (T2D) compared with no exercise at all, according to a study presented at EASD 2020.